You searched for "Prostate Cancer"

204 results found

BXTAccelyon becomes global distribution partner for new online prostate MRI self-learning tool to enhance prostate cancer diagnosis

BXTAccelyon, the leading low dose rate (LDR) brachytherapy partner to hospitals and clinics worldwide, and distribution partner for PrecisionPoint™, the...

Prostate Cancer UK: Faster Diagnosis Standard: Short course (20 weeks long) Deadline 5 Jan 2025 (Free)

You will learn some best practice models and drive change in your Trust, constructing a model with industry experts to deliver a new pathway that works for your patients. Unlock the potential to implement Faster Diagnosis Standards and accelerate diagnosis for men affected by prostate cancer with our free 20-week leadership programme. Guided by expert programme managers, you'll shape and implement your own project and gain crucial leadership and change management skills. We’ll support you from the initial planning stages of your project through to implementation and review.

Prostate Cancer UK: Clinical Champions: Flagship long course (18 months) Deadline 2 Feb 2025 (Free)

Our award-winning long course, the Clinical Champions is all about driving change in your trust and broadening your professional soft-skill set. Our programme will support and inspire you to drive meaningful improvements for people living with or at risk of prostate cancer. To apply, you’ll need an improvement project and to demonstrate how you’d like to expand your leadership skills. As part of the programme you will receive: - Training on change leadership, system leadership, improvement science and implementing an improvement project. - Virtual improvement group meetings that allow time to connect with peers. - Individual support around your improvement ambitions and leadership development. - Opportunities to meet and network with inspiring leaders.

New ultrasound imaging technique reliably spots prostate cancer, initial patient trial reveals

A groundbreaking new imaging approach developed by researchers at Heriot-Watt University has shown ‘extremely encouraging’ results in early-stage clinical trials on prostate cancer at the Western General Hospital in Edinburgh, Scotland. The ongoing clinical trial demonstrated an initial 94% sensitivity...

NHS Greater Glasgow and Clyde Prostate Cancer Nurse Specialist wins Continence and Urology Nurse of the Year at BJN Awards 2025

Leann McLaughlin, a Uro-Oncology CNS who specialises in prostate cancer at Inverclyde Royal Hospital, NHS Greater Glasgow and Clyde, has won Urology and Continence Nurse of the Year at the British Journal of Nursing (BJN) Awards 2025. The prestigious event...

Catheters and incontinence after radical prostatectomy: Preparing (but not scaring) men

Every year about 6000 men in the UK undergo radical prostatectomy (RP) for treatment of prostate cancer [1]. Despite surgical advances, RP continues to be associated with significant side-effects including urinary incontinence (UI) [2]. Immediately following removal of the urinary...

Consensus statements on PSA testing in asymptomatic men in the UK

In January 2016, the UK National Screening Committee once again recommended against a systematic population screening programme for prostate cancer due to the, as yet, insufficient evidence that the benefits of screening would outweigh the harm to the population as...

Has laparoscopic radical prostatectomy had its day?

Over recent years there has been a massive uptake in robotic surgery particularly for robot-assisted prostatectomy. The drive for this has been patient and physician led with little in the way of prospective randomised trials showing benefits over established operative...

The Lister Royal College of Surgeons of England / BAUS Accredited Robotic Urological Fellowship Programme

Robotic fellowship training in the UK – overview Robotic surgery has increased in popularity since its introduction in 2003. Its validation in a growing number of operative procedures has increased its acceptance nationwide and its usage is becoming widespread. Initial...

The survival impact of neoadjuvant hormonal therapy before radical prostatectomy

There is increasing evidence for the role of radical prostatectomy in select patients with T3-T4 prostate cancer (as part of multimodal therapy). This retrospective multicentre study explored the benefit of neoadjuvant hormonal therapy before radical prostatectomy specifically in patients with...

Use of Clavien-Dindo classification in urology part 1 – pelvic surgery

There is no widely accepted system to classify postoperative complications. It is necessary to compare the outcome and complications while validating a new surgical procedure or one of the surgical approaches of a particular condition. Several parameters have long been...

Robotic Urology Fellowship at UCLH

In November 2014, approaching my final year of training (ST7) in the West of Scotland (WoS) and just recently armed with my FRCS (Urol), I was at a crossroad in my clinical career. I was keen to pursue a consultant...